The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*
Abstract
Objective: To perform an analysis of healthcare resource utilization with intensive insulin therapy, which has recently been shown to reduce morbidity and mortality rates of mechanically ventilated critically ill patients in a surgical intensive care unit. Design: A post hoc cost analysis. Setting: Surgical intensive care unit. Patients: Patients were 1548 mechanically ventilated patients admitted to a surgical intensive care unit. Interventions: A post hoc cost analysis was conducted based on data collected prospectively as part of a large randomized controlled trial. The analysis performed was a healthcare resource utilization analysis in which the cost of hospitalization in the intensive care unit was determined based on length of stay and the frequency of crucial cost-generating morbid events occurring in the intensive and conventional insulin treatment groups. Sensitivity analyses were performed to evaluate the robustness of the findings. Discounting of costs was not performed as treatment was limited to the intensive care stay and follow-up was not continued beyond hospitalization. Measurements and Main Results: In the intensive treatment group, total treatment cost was 109,838 Euros (144 Euros per patient). In the conventional treatment group, total treatment cost was 56,359 Euros (72 Euros per patient). The excess cost of intensive insulin therapy was 72 Euros per patient. The total hospitalization cost in the intensive treatment group was 6,067,237 Euros (7931 Euros per patient) compared with 8,275,394 Euros (10,569 Euros per patient) in the conventional treatment group. The excess cost of intensive care unit hospitalization in the conventional vs. intensive treatment group was 2638 Euros per patient. These intensive care unit benefits were not offset by additional costs for care on regular wards. Conclusions: Intensive insulin therapy, which reduces morbidity and mortality rates of mechanically ventilated patients admitted to a surgical intensive care unit, is associated with substantial cost savings compared with conventional insulin therapy. LEARNING OBJECTIVES On completion of this article, the reader should be able to: Describe intensive insulin therapy. Identify the costs of conventional and intensive insulin therapy. Use this information in a clinical setting. Dr. Van den Berghe has disclosed that she is the recipient of grant/research funding from LifeScan and NovoNordisk. Dr. Hilleman has disclosed that he was on the speakers bureau of Roche and was/is on the speakers bureau of Abbott, LifeScan, and Pfizer. Mr. Wouters and Dr. Kesteloot have disclosed that they have no financial relationships with or interests in any commercial companies pertaining to this educational activity. The authors have disclosed that the use of insulin has not been approved by the FDA as discussed in this article. Wolters Kluwer Health had identified and resolved all faculty conflicts of interest regarding this educational activity. Visit the Critical Care Medicine Web site (www.ccmjournal.org) for information on obtaining continuing medical education credit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Effect of Severe Burn Injury on Substrate Cycling by Glucose and Fatty Acids
Wolfe, R. R., Herndon, D. N., Jahoor, F., Miyoshi, H., & Wolfe, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170702 · Cited by 467
Cited by
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Glycemic variability: A strong independent predictor of mortality in critically ill patients.
Krinsley, J. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b38d2 · Cited by 729
Jacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
Metadata
- Authors
- Van den Berghe, G., Wouters, P. J., Kesteloot, K., & Hilleman, D. E.
- Venue
- Critical Care Medicine
- Published
- 2006-03
- Volume
- 34
- Issue
- 3
- Pages
- 612-616
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2055196372
- Cited by
- 201
- References
- 4
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*. https://app.cochat.ai/papers/10.1097/01.ccm.0000201408.15502.24
- The paper
- Van den Berghe, G., Wouters, P. J., Kesteloot, K., & Hilleman, D. E. (2006). Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000201408.15502.24
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.